PolyProx Therapeutics raised €4.0M in a Seed round in Apr 2019. The company is based in Cambridge, UK. Investors in the round: Cambridge Innovation Capital, Rt Capital Management, University of Cambridge Enterprise. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
